Trial Search Results

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Terbutaline

Phase:

N/A

Eligibility


Inclusion Criteria::

   - nonreassuring fetal heart rate tracing

Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth
restriction, prior cesarean section

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Yasser El-Sayed
6507233198
Not Recruiting